Researchers analyzed data on COVID-19 patients from a UK database and compared it to rates of the digestive issues for the individuals after infection, as well as to a control group. They found that 30 days after COVID-19 infection, patients had an increased risk of 41% for gastroesophageal reflux disease; 38% for GI dysfunction; 36% for pancreatic disease; 35% for severe liver disease; 27% for nonalcoholic liver disease; 23% for peptic ulcers; and 21% for gallbladder disease.
“COVID-19 patients are at a higher risk of developing digestive diseases,” the authors of the study from Southern Medical University in Guangzhou, China, wrote. “The risks exhibited a stepwise escalation with the severity of COVID-19, were noted in cases of reinfection, and persisted even after one year follow-up.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.